IFNB1 and cancer: The fact that IFN-β inhibited cell proliferation of Huh7 cells via cell cycle arrest, but did not increase TRAIL sensitivity in the Huh7 cells, suggests that IFN-β might induce synergy with anti-cancer agents responsive to TRAIL-resistant cells.